"As of July 2024, 16.3% of U.S. households had at least one GLP-1 user. Nearly half of adopters reported taking the medication specifically for weight loss rather than diabetes management. About 34% of users discontinue within the sample period, and when they stop, candy and chocolate purchases rise 11.4% above pre-adoption levels."